# ZEGFROVY

NDC: 84694-102
Generic name: Sunvozertinib
Labeler / Manufacturer: Dizal Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20261022

FDA application: NDA219839

## Active ingredients

- SUNVOZERTINIB: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84694-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84694-102